Bemarituzumab Suppresses Choroidal Neovascularization in Mice by Downregulating Melanoma Cell Adhesion Molecule and Yes-Associated Protein 1
- 27 April 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (5) , 1099-1108
Abstract
In recent years, some fibroblast growth factors (FGFs) have been reported to be promising therapeutic targets for neovascular age-related macular degeneration (nAMD). Interestingly, we found that the FGFR2b inhibitor bemarituzumab (FPA144) exerts a beneficial effect in a mouse choroidal neovascularization (CNV) model. Our current study aims to uncover the potential molecular mechanism by which FPA144 alleviates CNV. The effect of FPA144 was evaluated in a laser-induced CNV mouse model. Fundus fluorescein angiography (FFA), optical coherence tomography (OCT), and choroidal flat mounts were carried out for the quantitative assessment of CNV. Label-free quantitative proteomics analysis was performed to assess changes in molecular pathways. Primary cultured human umbilical vein endothelial cells (HUVECs) were used for further confirmation of the target pathway in vitro. FFA, OCT, and choroidal flat mounts demonstrate the protective effect of FPA144 in a mouse CNV model. Compared to the control group, the treated group has smaller vascular leakage areas or smaller CNV lesions. Proteomic analyses indicate that the melanoma cell adhesion molecule (MCAM, CD146)–Yes-associated protein 1 (Yap1) pathway may be involved in the effect of FPA144. Immunostaining of choroidal flat mounts and cryosections reveals decreased expression of CD146 and Yap1 in the vascular endothelial cells of the treated animals. Experiments on HUVECs further verify the inhibitory effect of FPA144 on vascular endothelial cells. Our findings demonstrate that FPA144 can efficiently inhibit the development of choroidal neovascularization in mice by downregulating CD146 and Yap1.Keywords
Funding Information
- Guizhou Provincial Science and Technology Department (Qiankehezhicheng [2020]4Y146)
- Natural Science Foundation of Zhejiang Province (LGD22H120001)
- Natural Science Foundation of Zhejiang Province (LTGC23H120001)
- Natural Science Foundation of Zhejiang Province (LTGD23H120001)
- State Key Laboratory of Ophthalmology, Optometry and Vision Science, Wenzhou Medical University (K03-20220205)
This publication has 49 references indexed in Scilit:
- CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signalingCellular and Molecular Life Sciences, 2022
- Fibroblast growth factor-21 alleviates phenotypic characteristics of dry age-related macular degeneration in miceExperimental Eye Research, 2022
- CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseasesScience China Life Sciences, 2021
- FGF2-induced STAT3 activation regulates pathologic neovascularizationExperimental Eye Research, 2019
- VEGF in Signaling and Disease: Beyond Discovery and DevelopmentCell, 2019
- FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in MiceCell Reports, 2017
- Pathophysiology and Mechanisms of Severe Retinopathy of PrematurityOphthalmology, 2015
- Anti-vascular endothelial growth factor for neovascular age-related macular degenerationCochrane Database of Systematic Reviews, 2014
- Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout miceProtein & Cell, 2014
- The Role of Mitogen-Activated Protein Kinase Activation within Focal Adhesions in Chemotaxis toward FGF-2 by Murine Brain Capillary Endothelial CellsExperimental Cell Research, 2001